Cotton

Quick links to important sections

Cotton

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cotton

Property Description
Active Ingredients Multiple plant extracts (e.g., Cotton Fiber, Flax Seed, Tobacco Leaf)
Form Sterile Solution for Injection
Pharmacological Class Non-Standardized Allergenic Extract (Immunological Agent)
General Purpose Diagnostic testing and basis for Immunotherapy (Hyposensitization)
Origin Natural (Plant-derived)

The drug known as Cotton is a specialized Biologic Product that falls under the classification of a Non-Standardized Allergenic Extract, which positions it as an Immunological Agent. This unique type of medication is primarily used to address allergic disease by modifying the body's defensive response rather than masking symptoms. This principle is clinically recognized for its long-term strategy in managing sensitivities to inhaled and contact allergens. As an extract derived from various plant sources, it is distinct from small-molecule chemical drugs, focusing on immune system engagement.


What Type of Medicine is the Cotton Extract?

The Cotton extract is an Immunological Agent classified as an Allergenic Extract by regulatory bodies, with its function focused on inducing hyposensitization. The preparation is a combination product of natural origin, containing various components that collectively target common environmental allergens, such as those found in fabrics and seeds. The intended route of administration is typically subcutaneous or intradermal, a characteristic method for administering allergenic extracts.

This preparation is specifically defined as non-standardized because the exact biological activity of its many components is determined by the quality and quantity of the source material extracts, distinguishing it from standardized products which rely on defined potency units.


What is the Composition of Cotton and Its General Purpose?

The composition of the Cotton extract features a complex mixture of extractable proteins and structural components obtained from multiple plant sources. These active ingredients include Cotton Fiber, Cotton Seed, Tobacco Leaf, Flax Seed, Agave Sisalana Fiber (Sisal), Ceiba Pentandra Fiber (Kapok), Corcorus Capsularis Fiber (Jute), and Iris Germanica Var. Florentina Root (Orris Root). The active moieties are suspended in an aqueous or glycerinated solution (Sterile Diluent).

Its overall general purpose is critical for two applications: to serve as a key tool for diagnostic testing to precisely identify patient sensitivities, and to provide the foundational extract base for long-term allergen-specific immunotherapy to help the body build tolerance.

What side effects are possible with Cotton?

Possible Side Effects and Safety Information

The official safety profile for the Cotton Allergenic Extract, classified as an Immunological Agent, details adverse reactions primarily related to the immune system’s response to the extract.


Adverse Reaction Scope

Category Description
Key Adverse Reaction Categories Immune-mediated local reactions and systemic hypersensitivity reactions.
Frequency Classification Very Common events are typically local injection site symptoms (e.g., redness, swelling, itching, tenderness). Systemic reactions, such as generalized hives, wheezing, and rhinitis, are classified as Uncommon or Rare (occurring in le 7% of patients in some clinical reviews).
System-Organ Classes Involved The documented adverse effects fall primarily under Immune System Disorders, Skin and Subcutaneous Tissue Disorders, Respiratory, Thoracic and Mediastinal Disorders, and General Disorders and Administration Site Conditions.
Serious Adverse Reactions (SAR) Anaphylaxis is the most serious reaction, documented in regulatory warnings as a potentially life-threatening systemic hypersensitivity requiring immediate attention. Severe bronchospasm and circulatory collapse are also officially listed as possible SARs.
Dose- or Exposure-Related Patterns Systemic reactions are noted in regulatory labels as being more likely during the initial phase of dose escalation. Most systemic reactions are documented as occurring within 30 minutes following administration, which governs observation periods.

Safety Restrictions and Limitations

Official prescribing information establishes specific constraints on the use of this product:

  • Uncontrolled Asthma: The extract is contraindicated in individuals with severe, unstable, or uncontrolled asthma, as this condition significantly increases the risk of a severe systemic reaction.
  • Concurrent Medications: The product is restricted in patients receiving Beta-blockers, as these medications may heighten the severity of an anaphylactic reaction and may reduce the patient’s responsiveness to epinephrine, which is required for treating severe systemic reactions.

Population and Regulatory Context

Safety data indicates that the profile in the Pediatric Population is generally similar to adults, but requires careful individual dose adjustment. Regarding Pregnancy and Lactation, official documents advise that the extract should be administered only if the potential benefit justifies the potential risk, due to limited human data. The entire safety framework is based on the authoritative regulatory classification for Non-Standardized Allergenic Extracts.

Overdose and Emergency Response

The official regulatory documents for the Cotton allergenic extract define an overdose scenario as a severe life-threatening systemic reaction, often classified as anaphylaxis or anaphylactic shock. These reactions may be triggered by high doses or extreme patient sensitivity and necessitate immediate emergency management.

Documented manifestations of a severe systemic reaction include widespread skin symptoms such as generalized urticaria, pruritus, and angioedema. Respiratory involvement is significant, presenting as wheezing, laryngeal edema, and dyspnea. Cardiovascular signs such as hypotension and neurological effects like dizziness or faintness are also listed in official labeling.

The regulatory requirements mandate that immediate medical attention must be sought for any reaction occurring during or after leaving the clinical setting. Treatment requires the immediate availability and administration of Epinephrine Hydrochloride 1:1000 alongside supportive measures such as oxygen, volume expanders, and intubation. Furthermore, regulatory documents stipulate a mandatory observation period of at least 20 to 30 minutes following administration to detect and manage a reaction promptly.

Patients with underlying conditions, including severe asthma, cardiovascular disease, or those receiving beta-blockers, are noted in official labeling as being at increased risk for these severe outcomes, which may be unresponsive to standard epinephrine treatment.

Therapeutic Uses of Cotton

What Medical Cotton Treats: Uses and Benefits

Medical cotton is primarily applied across domains where additional symptomatic support is needed, particularly in situations involving minor symptoms related to localized discomfort and symptoms related to inflammatory or irritative states. It is considered relevant in supportive care for common conditions presenting with acute episodes of skin disruption, such as minor cuts, scrapes, abrasions, and small burns, where management of wound drainage is appropriate.

This category of products is intended to cover and protect a wound, absorb exudate, and may assist in the management of exudate. This material provides support that helps ease the overall symptom burden and assists with maintaining functional stability when symptoms interfere with routine activities.

It is relevant when groups of symptoms appear suddenly or fluctuate, providing temporary assistance in symptom stabilization. It is often used during phases where the patient experiences heightened discomfort, and may assist with managing discomfort or tension.


Quick Fact: Supportive management for Localized Discomfort and Discharge


Eligibility and Restrictions for Use

The eligibility for using the injectable medicine Cotton is strictly determined by regulatory criteria for Non-Standardized Allergenic Extracts, designed to mitigate the risk of severe systemic allergic reactions.

Contraindications and Restrictions

Cotton is absolutely contraindicated and must not be used in patients with severe, unstable, or uncontrolled asthma. Use is also prohibited in individuals with a history of any severe systemic allergic reaction to an allergen extract and in those with medical conditions that reduce the ability to survive anaphylaxis.

Use must be administered with extreme caution in patients taking beta-blocker medications, as these can interfere with emergency treatment. Injections should be temporarily withheld when a patient experiences fever from an infection or has severe acute symptoms of rhinitis or asthma.

Age and Physiological Status

The pediatric dosage is generally the same as that for adults, though use in children under five years may not be fully established for all extracts in this class. For women who are pregnant, the extract should be given only if clearly needed. However, for women already on a maintenance dose, pregnancy is not an indication to stop immunotherapy. Use requires caution when administered to a nursing woman.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

The official regulatory interaction profile for Cotton (Non-Standardized Allergenic Extract) currently contains no documented information regarding co-administered medicinal products or substance categories. Official government labeling does not list any specific interacting medicines. Furthermore, the available regulatory documents do not specify any mechanistic basis for interactions, such as pharmacokinetic (CYP enzyme) or pharmacodynamic effects. Consequently, there are no documented interaction-related restrictions or do-not-combine rules provided in regulatory literature.

Interaction Classifications (High-Level)

Regulatory documents do not assign a specific interaction severity classification to Cotton as there are no documented interactions to categorize. The regulatory basis for this profile is defined by the absence of publicly available, verifiable government-sourced data for interaction-context constraints. There are no officially documented requirements for separating the administration of Cotton from other medicinal products.


Resulting Interaction Structure

Official Interaction Statements:

  • Regulatory documents do not explicitly list any medicinal products or substance categories with which Cotton has a documented interaction.
  • There are no formally stated pharmacokinetic or pharmacodynamic interaction mechanisms documented in official prescribing information.
  • No combinations are classified as contraindicated due to an officially documented interaction risk.
  • No interactions with food, alcohol, or supplements are documented in official regulatory sources.

Connection to the Overall Interaction Profile:

The overall interaction profile is structurally defined by the absence of official constraints found in government labeling. Regulatory documents do not specify any prohibitions, dose spacing rules, or documented mechanistic interaction patterns (enzyme or transporter effects) with co-administered substances. This means the official profile currently contains no explicit interaction requirements.

Mechanism of Action

The Cotton allergenic extract functions as an immunological agent by fundamentally modulating the immune system's cellular and humoral response to specific plant proteins. This mechanistic process is achieved through two complementary domains.

T-Cell Reprogramming and Immune Regulation

This domain covers the extract's action on key immune cells. The controlled exposure to the antigen activates specialized regulatory T-lymphocytes ( Tregs), which release inhibitory signals like IL-10 and TGF-beta. This cytokine modulation suppresses activity within the Th2 pathway, influencing the differentiation of T-lymphocytes.

Antibody Class Switching and Functional Blockade

This focuses on the resulting humoral changes. The signals from the Tregs direct B-lymphocytes to shift production from the IgE antibody isotype to the IgG4 isotype. These IgG4 molecules then functionally intercept the circulating allergen, preventing it from cross-linking receptors on Mast Cells and Basophils, resulting in the modulation of the immediate hypersensitivity cascade.

Dosage and Administration Information

How to Use Cotton: Official Administration Guidelines

These instructions define the standardized procedure for using the cotton pledget delivery system. This material is used as a vehicle for the local delivery of a specific drug solution and must be administered by a healthcare professional.


Administration Scope

Feature Official Requirement
Route of Administration Intranasal (via saturated cotton pledget).
Dosing Schedule Administer 4 mL of the specified drug solution per application site. Maximum total dose and maximum duration of placement must be adhered to.
Preparation Stacked cotton pledgets must be saturated with 4 mL of the drug solution using a syringe before insertion.
Special Conditions Requires administration by a trained healthcare professional. Cotton must be removed immediately after the maximum duration or upon signs of an adverse event.

Official Procedural Steps

Following the Preparation and Saturation requirements, the administration follows a strict sequence:

  • Prepare and Saturate: Use a syringe to saturate the stacked cotton pledgets with the 4 mL volume of the drug solution.
  • Placement and Quantity: Using sterile cotton tweezers, insert the pledget(s) into the specified anatomical location (e.g., nasal cavity), ensuring the maximum allowed quantity (e.g., two pledgets) is not exceeded per site.
  • Removal and Disposal: Remove the cotton at or before the maximum specified duration (e.g., 20 minutes). Immediately dispose of the used cotton pledget(s) according to institutional biosafety procedures.

This structured approach, governed by strict rules on preparation, placement, and time limits, ensures the controlled and proper use of the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Pivotal Applications in Healthcare

Research has historically focused on cotton's properties as a biomaterial, including its softness, absorbency, and ability to withstand sterilization. Contemporary clinical studies typically involve modified cotton materials or its use as a comparative standard, rather than the raw fiber alone.

Clinical Outcomes and Comparative Data

Specific clinical trials have explored the material's role in supportive care and barrier systems:

  • Dental Sealant Isolation: A randomized controlled trial compared the use of cotton rolls versus alternative isolation devices during the placement of dental sealants. The study assessed the retention rates of the sealants over 6 and 12 months, providing data on the efficacy of cotton-based isolation in a controlled dental setting.
  • Supportive Footwear: Research investigated the potential for cotton socks to reduce the incidence of skin lesions in pediatric patients undergoing post-operative foot correction with leg-foot splints. The study aimed to evaluate whether cotton was associated with a difference in skin tolerability compared to elastic compression wraps.
  • Dermatological Comfort: Another trial focused on patient preference and comfort in dermatological procedures, specifically examining whether using a cotton dampener with vibratory anesthetic devices was preferred by patients over the device alone across various anatomical sites.

Barrier and Durability Studies

Observational and longitudinal studies have investigated the durability of 100% cotton fabric when used as a sterile barrier system in hospitals. Findings have focused on the impact of repeated washing and reprocessing cycles on physical properties, such as thread integrity and water absorption, while monitoring the material's barrier performance against microbial penetration over time.

Frequently Asked Questions (FAQ)

Common questions about Cotton (FAQ)

Q: Why is Cotton only available by prescription?

A: Cotton is only available by prescription because regulatory requirements specify that administration should be performed by a trained healthcare professional. This is necessary because the product must be given in a medical setting that is properly equipped to manage the rare possibility of a severe systemic allergic reaction.

Q: Is Cotton considered a long-term or short-term treatment?

A: As an agent used for allergen immunotherapy, the use of Cotton is generally considered a long-term treatment strategy. Clinical guidelines suggest that completing a course of at least three years may be associated with achieving sustained clinical benefit and immunological tolerance.

Q: What is the key evidence supporting the use of Cotton?

A: Official product information states that clinical data supports the extract's use. This evidence supports its use in the reduction of symptoms caused by specific allergens, which is confirmed through initial diagnostic skin tests or laboratory testing.

Q: Can Cotton make you feel tired or drowsy?

A: Drowsiness or fatigue are not commonly listed as primary or very common adverse reactions in the official regulatory documents for the extract itself. Patients experiencing systemic reactions are advised to consult their administering physician.

Q: Is 'headache' a very common side effect listed for Cotton?

A: The most common side effects listed in official documents are local reactions occurring at the administration site, such as redness or swelling. Headache is not classified as a very common adverse event in the official prescribing information for this type of extract.

Q: Can people with heart conditions safely use Cotton?

A: Official labels note that the product may not be suitable for patients with underlying medical conditions that could reduce their ability to survive a serious allergic reaction. The label advises caution or restriction for patients taking beta-blocker medications, as these drugs may interfere with emergency treatment.

Q: Can women who are planning pregnancy use Cotton?

A: Regulatory guidance advises that this extract should be administered during pregnancy only if the potential benefit clearly justifies the potential risk. Women who are planning pregnancy are advised to consult with their healthcare provider regarding their treatment schedule.

Q: What happens if I stop taking Cotton suddenly?

A: Regulatory documents do not address withdrawal symptoms upon sudden cessation. However, long-term evidence suggests that if the patient has not completed the minimum recommended treatment duration, stopping the extract may result in the loss of sustained clinical benefit and immune tolerance.

Q: How long does it typically take to see the effects of Cotton?

A: According to guidance on allergen immunotherapy, the onset of clinical efficacy typically begins after two to four months of starting the treatment schedule. This is generally when evidence of changes in the body’s immune response may begin.

Q: What does the FDA label say about Cotton's purpose?

A: The FDA label specifies that the extract is indicated for two main purposes: to be used in skin test diagnosis and to serve as the basis for immunotherapy. Immunotherapy is intended to reduce a patient's allergic symptoms caused by environmental allergens.

Q: Do studies suggest Cotton is effective for everyone who uses it?

A: Studies on allergen immunotherapy suggest that it may not be clinically effective in all allergic individuals. The resulting effectiveness can vary depending on the specific allergen being treated and the patient's underlying condition.

Q: What is the difference between Cotton and a generic version of the same medicine?

A: The extract is classified as Non-Standardized Allergenic Extract. This means it is a complex biologic product where its exact biological activity is linked to the variability of the source material, which distinguishes it from standardized or chemically generic drugs.

Q: Is Cotton addictive or habit-forming?

A: Regulatory documents do not list the extract as a controlled substance. Furthermore, the regulatory information does not cite potential for addiction or habit-forming behavior in this therapeutic class.

Q: Does Cotton affect sleep patterns?

A: Sleep disturbance is not documented as a common or primary adverse reaction of the extract itself in official prescribing information. Patients should consult their administering physician about any persistent sleep issues.

Q: What should I do if I forget to take my Cotton dose?

A: Since the product is administered by a healthcare professional on a specific schedule, official regulatory information advises patients to consult their administering physician immediately for specific instructions on managing a missed dose.

Q: Does Cotton need to be used at the same time every day?

A: The overall schedule for the extract is determined by the healthcare professional who administers the product. They define the frequency and timing based on the individual's treatment phase and specific clinical protocol.

Q: Does the efficacy of Cotton decrease over time?

A: Long-term follow-up data from studies on allergen immunotherapy suggest that the clinical and immunological benefits can be sustained for years after patients complete the minimum recommended treatment duration.

Q: Are there different strengths of Cotton available?

A: Yes, the extracts are supplied as sterile stock concentrates in various potencies. Official labeling uses metrics such as weight-per-volume or Protein Nitrogen Units (PNU) per milliliter to define these different available strengths.

Q: Is it possible to develop a tolerance to Cotton?

A: Yes, developing tolerance is the key objective of this treatment. Allergen immunotherapy is designed to induce a state of immunological tolerance, or hyposensitization, to the specific allergens contained in the extract.

Q: Can Cotton affect the results of lab tests?

A: The extract is indicated for use in diagnostic skin testing, and the results of these tests must be interpreted by a healthcare professional. These results require careful correlation with the patient's medical history.

Q: Does taking Cotton affect driving or operating machinery?

A: Official labeling does not contain a specific warning regarding driving or operating machinery. However, patients are advised that they should be cautious regarding potential systemic adverse reactions that could potentially affect their ability to perform these tasks safely.

Q: What is the general expectation for treatment success with Cotton?

A: Treatment success is generally measured by several factors, including a reduction in allergen-induced symptoms and a decreased need for symptomatic medication. An overall improvement in the patient's quality of life is an important outcome generally assessed.

Q: Does Cotton have a 'black box warning'?

A: Yes, the extract is subject to a Boxed Warning in its regulatory documents. This is due to the risk of severe, life-threatening systemic reactions, including anaphylaxis, which necessitates seeking immediate medical attention.

Q: Do clinical trials for Cotton show long-term safety data?

A: While the extract is non-standardized, real-world studies on allergen immunotherapy demonstrate sustained effectiveness and safety. Clinical follow-up data has tracked patients for several years after treatment was initiated.

Q: Is it safe to take Cotton if I have high blood pressure?

A: High blood pressure itself is not a contraindication. However, the label restricts use in patients taking beta-blocker medications, which are often prescribed for hypertension. This is because beta-blockers may interfere with the body’s ability to respond to emergency epinephrine.

How should Cotton be stored and disposed of?

How to Store and Dispose of Cotton Extract

Storage of the Cotton allergenic extract, a sterile solution, is strictly defined by regulatory requirements to maintain product potency.

  • Mandatory Storage: The extract must be stored under refrigeration at a temperature between 2 C and 8 C. The product must not be frozen as this can cause loss of stability and precipitation.
  • Handling: The solution must be visually inspected before use for any particulate matter or discoloration; if present, it must be discarded. The medicine must be kept out of the reach of children.
  • Disposal: Used needles and syringes must be disposed of immediately in a designated puncture-resistant sharps container. Any unused or expired extract must be discarded according to local, state, and federal regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cotton found in:

A-Z Index: